4552 — JCR Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥79bn
- ¥84bn
- ¥43bn
Annual cashflow statement for JCR Pharmaceuticals Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3,422 | 8,653 | 19,404 | 5,412 | 7,244 |
| Depreciation | |||||
| Non-Cash Items | 57 | 47 | -306 | -733 | 416 |
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 16 | -252 | -11,754 | -12,175 | -1,545 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4,929 | 10,340 | 9,289 | -5,499 | 9,312 |
| Capital Expenditures | -4,838 | -7,527 | -11,333 | -8,560 | -2,095 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 677 | 4,237 | 8,083 | -6,442 | -595 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4,161 | -3,290 | -3,250 | -15,002 | -2,690 |
| Financing Cash Flow Items | -2 | 1 | — | -1 | -46 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,048 | 8,304 | -2,179 | 1,948 | -2,031 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2,836 | 15,332 | 4,472 | -17,454 | 5,477 |